Department of Pathology, City of Hope National Medical Center, Duarte, CA, 91010, USA.
Department of Pathology, Beijing Tongren Hospital, Capital Medical University, 100730, Beijing, China.
Leukemia. 2022 Aug;36(8):2064-2075. doi: 10.1038/s41375-022-01623-z. Epub 2022 Jun 13.
Extra-nodal NK/T-cell lymphoma, nasal type (ENKTCL) is a highly aggressive Epstein-Barr virus associated lymphoma, typically presenting in the nasal and paranasal areas. We assembled a large series of ENKTCL (n = 209) for comprehensive genomic analysis and correlative clinical study. The International Lymphoma Prognostic Index (IPI), site of disease, stage, lymphadenopathy, and hepatomegaly were associated with overall survival. Genetic analysis revealed frequent oncogenic activation of the JAK/STAT3 pathway and alterations in tumor suppressor genes (TSGs) and genes associated with epigenomic regulation. Integrated genomic analysis including recurrent mutations and genomic copy number alterations using consensus clustering identified seven distinct genetic clusters that were associated with different clinical outcomes, thus constituting previously unrecognized risk groups. The genetic profiles of ENTKCLs from Asian and Hispanic ethnic groups showed striking similarity, indicating shared pathogenetic mechanism and tumor evolution. Interestingly, we discovered a novel functional cooperation between activating STAT3 mutations and loss of the TSG, PRDM1, in promoting NK-cell growth and survival. This study provides a genetic roadmap for further analysis and facilitates investigation of actionable therapeutic opportunities in this aggressive lymphoma.
结外 NK/T 细胞淋巴瘤,鼻型(ENKTCL)是一种高度侵袭性的 EBV 相关淋巴瘤,通常发生在鼻腔和鼻旁区域。我们收集了大量的 ENKTCL(n=209)进行全面的基因组分析和相关的临床研究。国际淋巴瘤预后指数(IPI)、疾病部位、分期、淋巴结病和肝肿大与总生存相关。遗传分析显示 JAK/STAT3 通路的频繁致癌激活以及肿瘤抑制基因(TSGs)和与表观遗传调控相关基因的改变。包括使用共识聚类的复发性突变和基因组拷贝数改变的综合基因组分析,确定了七个不同的遗传簇,与不同的临床结果相关,从而构成了以前未被识别的风险组。来自亚洲和西班牙裔人群的 ENTKCL 的遗传特征显示出惊人的相似性,表明存在共同的发病机制和肿瘤进化。有趣的是,我们发现了一种新的功能合作,即激活 STAT3 突变和 TSG PRDM1 的缺失,促进 NK 细胞的生长和存活。这项研究为进一步分析提供了遗传路线图,并为这种侵袭性淋巴瘤的治疗机会提供了研究方向。